0220-0532 : Arsenicum Bromatum 30 [Hp_c]/30[hp_c] Oral Pellet


NDC0220-0532
Labeler: Boiron
Product Type: Human OTC Drug
Drug Name: Arsenicum Bromatum
Dosage Form: Oral Pellet
Rev. Date: 


NDC Package Codes:

  • 0220-0532-41: 30 [HP_C] IN 1 TUBE (0220‑0532‑41)

Active Ingredients:

  • Arsenic Tribromide

Dosage Strength:

  • 30 [hp_C]/30[hp_C]

Related Products:

Based on records with the same trade name.
  • 15631-0051 Arsenicum Bromatum 6 [hp_x]/1 Oral Pellet by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc
  • 15631-0523 Arsenicum Bromatum 6 [Hp_x]/1 Oral Tablet by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc
  • 63545-177 Arsenicum Bromatum 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-178 Arsenicum Bromatum 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-179 Arsenicum Bromatum 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-180 Arsenicum Bromatum 100 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-181 Arsenicum Bromatum 200 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-182 Arsenicum Bromatum 500 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-183 Arsenicum Bromatum 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 63545-184 Arsenicum Bromatum 10 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 68428-226 Arsenicum Bromatum 30 [Hp_c]/1 Oral Pellet by Washington Homeopathic Products
  • 71919-084 Arsenicum Bromatum 30 [Hp_c]/Ml Oral Liquid by Washington Homeopathic Products

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0220-0532 QR Code

< Prev: 0220-0530Next: 0220-0536 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.